MLYS
Mineralys Therapeutics, Inc.
23.40$
+4.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.3% | +38.0% | -8.3% | -15.8% | -23.2% | +72.4% | -5.4% | +78.7% | +10.3% | -1.4% | +2.3% | |
| – | -6.1% | +39.2% | -8.3% | -15.8% | -23.3% | +72.6% | -5.4% | +78.9% | +10.3% | -1.3% | +2.0% | |
| – | -42.9% | +83.4% | -25.0% | +43.4% | +17.3% | +44.6% | -38.3% | +113.8% | -20.5% | -34.8% | +22.6% | |
| – | -6.8% | +43.1% | -8.1% | -15.3% | -24.8% | +73.1% | -5.3% | -33.0% | +201.8% | -1.6% | +2.4% | |
| – | -22.6% | +83.2% | +47.9% | +10.3% | -53.2% | -8.6% | +65.6% | +6.1% | -35.7% | -2.6% | +694.5% | |
| – | -22.6% | +83.2% | +47.9% | +10.3% | -53.2% | -8.6% | +65.6% | +6.1% | -35.7% | -2.6% | +31.3% | |
| – | -89.2% | +609.0% | -59.9% | +82.0% | -84.6% | -22.1% | +748.3% | -64.6% | +79.9% | -44.7% | -4.5% | |
| – | -8.7% | +36.0% | -11.6% | -18.3% | -19.3% | +78.6% | -8.2% | +83.8% | +12.2% | -1.3% | -13.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +12.0% | +9.9% | +0.9% | +0.3% | +6.4% | +23.1% | +7.9% | +14.1% | +2.8% | +2.3% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.